Xhosa
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Isihloko: Ugqirha oyiNtloko
Isikhundla: Intloko yeCandelo
Iprofayili yoBuqu: Ugqirha oyiNtloko, uNjingalwazi, uMphathi wePh.D., okwangoku unguMlawuli weSebe leHematology kwiSibhedlele sasePeking Tongren. Uphumelele kwiKholeji yezoNyango yasePeking Union ngo-2010, efunda kwiMedicine yeKlinikhi kwinkqubo yeminyaka esibhozo, waza wafumana isidanga sobuGqirha bezoNyango. Ubebandakanyeka ekuxilongeni nasekunyangeni iithumba zegazi (i-lymphoma, i-multiple myeloma, njl.njl.) kangangeminyaka engaphezu kwe-10, kwaye unamava amaninzi eklinikhi kunye nempumelelo ephezulu kwizifundo ekuxilongeni nasekunyangeni iintlobo ezahlukeneyo ze-lymphomas kunye ne-myelomas, kwaye ugxile kwi-immunotherapy ekujoliswe kuyo, i-chemotherapy, unyango lweeseli ze-CAR-T, ukufakelwa kweeseli ze-hematopoietic stem, kunye nokukhokela uphuhliso lokuxilongwa kunye nonyango olunezifundo ezininzi (MDT). Izinto anomdla kuzo kuphando lwakhe kunyango olujoliswe kwi-immunotherapy kunye nendlela yokuchasana namayeza onyango lwe-lymphoma, kwaye uphethe iqela leNational Natural Science Foundation of China. Upapashe amaphepha obuchwephesha angaphezu kwama-40, kuquka amaphepha angaphezu kwama-30 ane-SCI indexed, apapashwe kwiLancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, kunye nezinye iijenali kunye neejenali. Upapashe kwiLancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, kunye neLeukemia & Lymphoma. Ungumhleli-kunye weStandard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, kunye neMedical Oncology. Wanikwa ibhaso elithi “Respect for Life-2017 Glory to Healers-Youth Innovation Award”, ibhaso elithi “Tongren Elite” ngo-2020, ibhaso elithi “Tongren Hospital Outstanding Young Talent” ngo-2020, kunye nebhaso lokuqala elithi “Tongren Hospital Outstanding Young Talent” ngo-2020. I-Tongren Hospital Outstanding Young Talent” ngo-2020, '35 Young Oncologists Under 35 with the Most Potential in China'. Amacandelo ezemfundo: Ilungu eliselula leSebe leHematology le-Chinese Medical Association; Ilungu elihlala lihleli leKomiti yeLymphoma Immunotherapy yeBeijing Cancer Prevention and Control Society; Ilungu elihlala lihleli leKomiti yeMyeloma ye-China Medical Education Association; Ingcali yeNational Natural Science Foundation yaseTshayina. Ungumhleli odibeneyo we-Aging Pathobiology and Therapeutics, ilungu lebhodi yabahleli be-Chinese Journal of Cancer Prevention and Control, ilungu lebhodi yabahleli eliselula leConcord Medical Journal, kunye nomhlalutyi weJournal of Hematology & Oncology kunye neCancer Biology & Medicine.

Wang Liang